US Home Healthcare Market (2025-2030)
The US Home Healthcare Market was valued at $109719.9 Million in 2025 and projected to reach to $167795.6 Million by 2030, representing a compound annual growth rate of 8.9%. The US home healthcare market is positioned for sustained growth through 2030, driven by structural shifts in healthcare delivery preferences and demographic trends.
US Home Healthcare Market Trends and Insights
- This growth trajectory reflects the US healthcare system's shift toward patient-centric, cost-effective care delivery models.
- The US market benefits from an aging population, rising prevalence of chronic diseases, and increased insurance coverage for home-based services, positioning the US as a critical driver of innovation in remote patient monitoring and telehealth integration. Driving the US market's 8.9% compound annual growth rate are favorable reimbursement policies, technological advancement in home health devices, and caregiver shortages that incentivize home-based alternatives.
- The US regulatory environment, including Medicare and Medicaid support, continues to expand coverage for skilled nursing, physical therapy, and personal care services delivered in residential settings.
- By 2030, the US home healthcare sector is expected to capture an increasingly larger share of total healthcare spending as providers and payers recognize the clinical and economic benefits of keeping patients at home..
Key Market Statistics
- CAGR (2025-2030) 8.9% CAGR
- Market Size, 2025 ~USD 109719.9 Million
- Forecast, 2030 ~USD 167795.6 Million
- Country US
US Home Healthcare Market Overview
Market Valuation Growth :
The US home healthcare market is valued at $109,719.9 million in 2025 and is projected to reach $167,795.6 million by 2030, representing a compound annual growth rate of 8.9%.
Aging Population Driver :
The US demographic shift toward an aging Baby Boomer population is significantly accelerating demand for home healthcare services, as seniors prefer aging-in-place solutions over institutional care facilities.
Chronic Disease Prevalence :
Rising incidence of chronic conditions such as diabetes, heart disease, and COPD in the US population is driving sustained demand for ongoing home-based medical management and monitoring services.
Insurance Coverage Expansion :
Increased insurance coverage and reimbursement policies in the US are making home healthcare more accessible and affordable, encouraging both patient adoption and provider investment in service expansion.
US Home Healthcare Market Dynamics
- Payers and providers are increasingly recognizing home healthcare as a cost-effective alternative to hospital and institutional care, with strong reimbursement support from Medicare and private insurers.
- Technological integration, including remote patient monitoring and telehealth capabilities, is enhancing service delivery and expanding addressable patient populations across the country. Regulatory support and workforce development initiatives are strengthening market fundamentals, though labor shortages remain a challenge.
- The market will continue to benefit from value-based care models that incentivize preventive and chronic disease management in home settings.
- Strategic consolidation among providers and increased investment in digital health infrastructure are expected to reshape competitive dynamics through 2030..
Related Ecosystem
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- JOHNSON & JOHNSON
Key Takeaways
- The US home healthcare market will grow from $109.7B in 2025 to $167.8B by 2030, representing an 8.9% CAGR.
- The US aging population and chronic disease prevalence are primary catalysts for sustained market expansion through 2030.
- The US Medicare and Medicaid reimbursement frameworks are expanding coverage, driving adoption of home-based care services.
- The US market is increasingly integrating telehealth and remote monitoring technologies to enhance home healthcare delivery and outcomes.
Home Healthcare Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | INSULIN DELIVERY DEVICES (Type) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 8.9% from 2025 to 2030 |
| Largest Segment | THERAPEUTIC PRODUCTS (Product) |
| Market Size Base Year (Billions) | ~USD 309.35 (2025) |
| Revenue Forecast (Billions) | ~USD 473.8 (2030) |
| Segments Covered | Product, Type, Product & Service |
US Home Healthcare Market Report Segmentation
3 segment dimensions are covered across the global market.
By Product
- Mobility Care Products
- Testing, Screening, & Monitoring Products
- Testing, Screening, And Monitoring Products
- Therapeutic Products
By Type
- Activity Monitors & Wrist Bands
- Blood Glucose Monitors
- Blood Pressure Monitors
- Cancer
- Canes
- Cardiovascular Diseases & Hypertension
- Cardiovascular Disorders & Hypertension
- Cholesterol Testing Products
- Coagulation Monitoring Products
- Colon Cancer Test Kits
- Crutches
- Diabetes
- Dialysis Equipment
- Drug & Alcohol Test Kits
- Ecg/Ekg Devices
- Eeg Devices
- Fetal Monitoring Devices
- Hearing Aids
- Hearing Disorders
- Heart Rate Monitors
- Hiv Test Kits
- Holter & Event Monitors
- Home Hba1C Test Kits
- Home Hemoglobin A1C Test Kits
- Home Sleep Testing Devices
- Hospice & Palliative Care Services
- Hospice And Palliative Care Services
- Infusion Therapy Services
- Inhalers
- Insulin Delivery Devices
- Iv Equipment
- Mobility Disorders
- Mobility Scooters
- Nebulizers
- Other Indications
- Other Therapeutic Products
- Ovulation & Pregnancy Test Kits
- Oxygen Delivery Systems
- Peak Flow Meters
- Pregnancy
- Pregnancy Care Services
- Pulse Oximeters
- Rehabilitation Therapy Services
- Respiratory Diseases
- Respiratory Therapy Services
- Skilled Nursing Services
- Sleep Apnea Therapeutic Devices
- Temperature Monitoring Devices
- Unskilled Care Services
- Ventilators
- Walkers & Rollators
- Wheelchairs
- Wound Care
- Wound Care Products
By Product & Service
- Product
- Service
Target Audience
- Healthcare Providers & Agencies : Home healthcare agencies and provider networks need US market data to benchmark performance, identify growth opportunities, optimize service offerings, and make informed expansion and investment decisions.
- Private Equity & Investors : Investment firms and venture capitalists require validated US market sizing and growth forecasts to evaluate acquisition targets, assess portfolio company performance, and identify high-potential investment opportunities in home healthcare.
- Medical Device & Technology Companies : Manufacturers of remote monitoring devices, telehealth platforms, and home healthcare technology need US market intelligence to guide product development, commercialization strategies, and partnership opportunities.
- Insurance & Payer Organizations : Health insurers and managed care organizations use US home healthcare market data to optimize care delivery models, evaluate cost-effectiveness, and develop reimbursement strategies that improve outcomes and reduce expenses.
- Healthcare Consultants & Analysts : Management consultants, equity research analysts, and healthcare strategists require comprehensive US market data to support client advisory work, investment research, and industry trend analysis and forecasting.
Key Companies in the US Home Healthcare Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| FISHER & PAYKEL HEALTHCARE | United States | Public Company | Therapeutic (CPAP, humidification, respiratory support devices),Monitoring, Testing, Screening (OSA and respiratory-related),Mobility Care and accessories, |
| NOVO NORDISK A/S | Denmark | Public Company | Therapeutic (insulins, GLP-1, obesity and rare disease therapies used at home),Testing, Screening, Monitoring (digital dose guidance, data connectivity around pens),Mobility Care, |
| APRIA HEALTHCARE GROUP, INC | United States | Private Company | Therapeutic (respiratory, sleep apnea, NPWT, other HME),Testing, Screening, Monitoring,Mobility Care and other HME, |
| CONMED CORPORATION | United States | Public Company | Therapeutic (home-use relevant),Testing, Screening, Monitoring,Mobility Care, |
| CONSORT MEDICAL | United Kingdom | Private Company | Therapeutic (drug delivery devices for home use),Testing, Screening & Monitoring–linked devices,Mobility Care–adjacent components, |
| HENRY SCHEIN | United States | Public Company | Therapeutic products for home use,Testing, screening, and monitoring,Mobility care and durable equipment, |
| HILL-ROM HOLDINGS, INC. | United States | Private Company | Therapeutic (incl. respiratory and non-invasive therapeutic surfaces),Mobility Care (beds, lifts, patient mobility solutions for home),Testing, Screening & Monitoring, |
| JABIL | United States | Public Company | Therapeutic devices (home-use),Testing, Screening & Monitoring devices,Mobility care hardware, |
| ROSSMAX INTERNATIONAL LTD | Taiwan | Public Company | Monitoring (BP monitors, thermometers, oximeters, scales),Therapeutic & Respiratory (nebulizers, suction units, aero spacers, heating pads, anti-decubitus mattresses),Testing & Screening (blood glucose systems, peak flow meters), |
| FRESENIUS MEDICAL CARE AG | Germany | Public Company | Therapeutic (home dialysis equipment, solutions, consumables),Testing, Screening, Monitoring,Mobility Care, |
| ABBOTT | United States | Public Company | Testing, Screening, and Monitoring,Therapeutic,Mobility Care, |
| LINDE PLC | United Kingdom | Public Company | Therapeutic (home oxygen, respiratory support),Testing, Screening, Monitoring,Mobility Care, |
| RESMED | United States | Public Company | Therapeutic (home respiratory and sleep therapy devices),Testing & Screening (home sleep diagnostics),Monitoring (remote patient monitoring and analytics), |
| KONINKLIJKE PHILIPS N.V. | Netherlands | Public Company | Therapeutic (incl. sleep and respiratory care, home ventilation),Testing, Screening, Monitoring (remote patient monitoring, diagnostics at home),Mobility Care and Personal Health Devices, |
| GE HEALTHCARE | United States | Public Company | Monitoring (vital signs, diagnostic cardiology, maternal-infant),Testing, Screening & Imaging-linked Home Pathways,Therapeutic & Infusion-linked Solutions, |
| A&D HOLON HOLDINGS COMPANY, LIMITED | Japan | Public Company | Testing, Screening, and Monitoring Devices,Therapeutic Devices (Ultrasonic Inhalers),Mobility Care, |
| CONVATEC GROUP PLC | United Kingdom | Public Company | Therapeutic products (wound, ostomy, continence, infusion sets) used at home,Monitoring / testing interfaces linked to infusion and chronic care,Mobility and home-care accessories for chronic-condition management, |
| AMEDISYS | United States | Private Company | Therapeutic (home-based therapies, including infusion support),Testing, Screening, Monitoring (clinical assessments, remote oversight),Mobility Care (rehabilitation, PT/OT, functional support), |
| INVACARE CORPORATION | United States | Private Company | Mobility Care (power and manual wheelchairs, ramps),Therapeutic & Lifestyle (pressure-relief, beds, safe patient handling),Testing, Screening & Monitoring (heart rate monitors, thermometers), |
| SUNRISE MEDICAL | United States | Private Company | Mobility Care (manual & power wheelchairs, scooters),Therapeutic & Rehabilitation Products (seating, positioning),Testing, Screening, Monitoring & Other, |
FISHER & PAYKEL HEALTHCARE
Fisher & Paykel Healthcare is a publicly traded medical device company founded in 1934 and headquartered in the United States. With 7,396 employees, the company designs and manufactures healthcare products and systems.
NOVO NORDISK A/S
Novo Nordisk A/S is a Danish pharmaceutical company founded in 1923 and publicly listed on stock exchanges. The company employs 67,900 people and focuses on biopharmaceutical research and development.
APRIA HEALTHCARE GROUP, INC
Appia Healthcare Group, Inc. is a privately held U.S. healthcare company founded in 2018 with 6,250 employees. The company provides healthcare services and solutions to patients and providers.
CONMED CORPORATION
CONMED Corporation is a publicly traded medical technology company founded in 1970 and based in the United States. With 3,900 employees, the company manufactures surgical and patient monitoring equipment.
CONSORT MEDICAL
Consort Medical is a privately held British medical device company founded in 1938 with 2,000 employees. The company develops and manufactures drug delivery and diagnostic devices.
HENRY SCHEIN
Henry Schein is a publicly traded healthcare company founded in 1932 and headquartered in the United States. With 25,000 employees, the company distributes medical, dental, and veterinary products and services.
HILL-ROM HOLDINGS, INC.
Hill-Rom Holdings, Inc. is a privately held medical technology company founded in 1915 and based in the United States. The company employs 10,000 people and manufactures patient care equipment and solutions.
JABIL
Jabil is a publicly traded electronics manufacturing services company founded in 1966 with 135,000 employees. The company provides design, engineering, and manufacturing services across multiple industries including healthcare.
ROSSMAX INTERNATIONAL LTD
Rossmax International Ltd. is a publicly traded Taiwanese medical device company founded in 1988. The company manufactures and distributes healthcare monitoring and diagnostic equipment.
FRESENIUS MEDICAL CARE AG
Fresenius Medical Care AG is a publicly traded German healthcare company founded in 1996 with 108,165 employees. The company provides dialysis products, services, and healthcare solutions globally.
ABBOTT
Abbott is a publicly traded American healthcare company founded in 1888 with 115,000 employees. The company manufactures and distributes pharmaceuticals, medical devices, diagnostics, and nutritional products.
LINDE PLC
Linde PLC is a publicly traded British industrial gases and healthcare company founded in 1879 with 65,034 employees. The company supplies gases, equipment, and services to healthcare and other industries.
RESMED
ResMed is a publicly traded medical device company founded in 1989 and headquartered in the United States. With 10,600 employees, the company manufactures cloud-connected medical devices for respiratory care and patient monitoring.
KONINKLIJKE PHILIPS N.V.
Koninklijke Philips N.V. is a publicly traded Dutch technology company founded in 1891 with 64,317 employees. The company manufactures healthcare equipment, consumer electronics, and lighting solutions.
GE HEALTHCARE
GE Healthcare is a publicly traded American healthcare technology company founded in 2022 with 54,000 employees. The company provides medical imaging, monitoring, and diagnostic equipment and services.
A&D HOLON HOLDINGS COMPANY, LIMITED
A&D Holon Holdings Company, Limited is a publicly traded Japanese medical device company founded in 1977 with 2,480 employees. The company manufactures and distributes healthcare monitoring and diagnostic equipment.
CONVATEC GROUP PLC
ConvaTec Group PLC is a publicly traded British medical technology company founded in 1978 with 10,910 employees. The company manufactures ostomy care, continence care, and wound care products.
AMEDISYS
Amedisys is a privately held American healthcare company founded in 1982 with 19,000 employees. The company provides home health, hospice, and personal care services.
INVACARE CORPORATION
Invacare Corporation is a privately held American medical device company founded in 1885 with 2,800 employees. The company manufactures mobility and respiratory care products for patients.
SUNRISE MEDICAL
Sunrise Medical is a privately held American medical device company founded in 1978 with 4,470 employees. The company manufactures and distributes mobility and accessibility products for patients.
Reasons to Buy this Report
- Market Size & Growth Validation : Obtain precise US market valuation data ($109.7B in 2025) and verified growth projections through 2030 to support investment decisions, business planning, and competitive positioning in the home healthcare sector.
- Demographic & Clinical Insights : Access detailed analysis of US aging population trends, chronic disease prevalence patterns, and patient preference shifts that are driving home healthcare adoption and market expansion opportunities.
- Reimbursement & Regulatory Intelligence : Understand US insurance coverage dynamics, Medicare/Medicaid reimbursement models, and policy changes affecting home healthcare profitability and market accessibility for providers and investors.
- Competitive Landscape Analysis : Identify market consolidation trends, provider strategies, and emerging competitors in the US home healthcare space to inform M&A decisions, partnership opportunities, and market entry strategies.
- Technology & Service Innovation Trends : Discover how remote patient monitoring, telehealth integration, and digital health solutions are transforming US home healthcare delivery and creating new revenue streams and competitive advantages.
Frequently asked questions
What is the current size of the US home healthcare market in 2025?
The US home healthcare market is valued at $109,719.9 million in 2025, with expectations to grow significantly through the forecast period.
What is the projected size of the US home healthcare market by 2030?
The US home healthcare market is forecast to reach $167,795.6 million by 2030, driven by demographic and policy tailwinds.
What is the CAGR for the US home healthcare market?
The US home healthcare market is expected to grow at a compound annual growth rate of 8.9% from 2025 to 2030.
What factors are driving growth in the US home healthcare market?
Key drivers in the US include an aging population, rising chronic disease prevalence, expanded Medicare and Medicaid coverage, caregiver shortages, and technological innovation in remote monitoring and telehealth.
How is the US home healthcare market expected to evolve by 2030?
By 2030, the US market will see increased integration of digital health technologies, expanded service offerings, and greater market consolidation as providers scale to meet growing demand.
RESEARCH METHODOLOGY
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.
Secondary Research
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), , Global Burden of Disease Study, and Centers for Medicare and Medicaid Services (CMS) were referred to identify and collect information for the global home healthcare market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the home healthcare market. The primary sources from the demand side include home healthcare service providers and home users. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.
A breakdown of the primary respondents is provided below:
*C-level primaries include CEOs, CFOs, COOs, and VPs.
*Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.
Source: MarketsandMarkets Analysis
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global home healthcare market. All the major service providers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/subsegments was done for the major players. Also, the global home healthcare market was split into various segments and sub-segments based on:
- List of major players operating in the product market at the regional and/or country level
- Product mapping of home healthcare providers at the regional and/or country level
- Mapping of annual revenue generated by listed major players from home healthcare (or the nearest reported business unit/product category)
- Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
- Summation of the market value of all segments/subsegments to arrive at the global home healthcare market
The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.
Market Size Estimation (Bottom-up Approach & Top-down Approach)
Data Triangulation
After arriving at the overall size of the global home healthcare market through the above-mentioned methodology, this market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.
Market Definition
Home healthcare refers to the medical attention, care, and support provided to patients at their residences by licensed healthcare workers, such as nurses, home health aides, and personal care aides. The home healthcare market includes products and services that can be set up remotely at a patient’s home.
Stakeholders
- Home Healthcare Equipment Manufacturers
- Home Healthcare Service Providers
- Home Health Software Vendors
- Nursing Service Providers
- Wound Care Product Manufacturers
- Pregnancy Care Product Manufacturers and Service Providers
- Supportive Care Product Manufacturers and Service Providers
- Diagnostic Companies
- Research & Development (R&D) Companies
- Business Research and Consulting Service Providers
- Medical Research Laboratories
- Venture Capitalists
Report Objectives
- To define, describe, segment, and forecast the global home healthcare market by product, service, indication, and region
- To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall home healthcare market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments with respect to five regions: North America, Europe, the Asia Pacific, Latin America, Middle East & Africa, and GCC Countries
- To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze company developments such as acquisitions, product launches & approvals, and expansions
- To benchmark players within the market using the proprietary “Competitive Leadership Mapping” framework, which analyzes market players on various parameters within the broad categories of business and product strategy
Get the Full Home Healthcare Market Report
Full forecast, segment splits, and company analysis for all Home Healthcare Market.
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report